B
Biostate AI
Biotech & Life Sciences · Palo Alto, United States · Founded 2023
Developing generative AI that can benefit human health by understanding and adapting to the dynamic nature of biological systems MoreLess
Biostate AI, founded in 2023, is a biotechnology company that combines artificial intelligence with RNA sequencing to create generative AI models for predicting disease progression and drug response. The company aims to make molecular diagnostics more accessible and affordable, likening its approach to a "Netflix model" for this field.
Biostate AI offers total RNA sequencing and free data analysis, partnering with academic researchers, hospital biorepositories, and pharmaceutical and biotech companies. This strategy allows them to leverage new technologies for scalable multiomic data generation. The company
Talent graph
Biostate AI's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Biostate AI has talent and traffic
team presence
Market sentiment
What the market is saying about Biostate AI
An AI-synthesized read of the highest-engagement posts about Biostate AI on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biostate AI on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.